Previous close | 47.19 |
Open | 47.61 |
Bid | 47.54 x 1100 |
Ask | 47.86 x 1400 |
Day's range | 46.91 - 47.93 |
52-week range | 32.82 - 47.93 |
Volume | |
Avg. volume | 36,614 |
Market cap | 494.862M |
Beta (5Y monthly) | 1.15 |
PE ratio (TTM) | 12.81 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.60 (1.25%) |
Ex-dividend date | 09 May 2024 |
1y target est | N/A |
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Kunal Bhatia joined as a Managing Director in the firm's Healthcare Investment Banking Group. He will be based in New York and report to Michael Margolis, R.Ph, Oppenheimer's Co-Head of Healthcare and Head of Healthcare Life Sciences Investment Banking.
Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank and subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that it has expanded its Technology Investment Banking group with the addition of Yogesh Amle as Managing Director, co-Head of Infrastructure Software. He will be based in Oppenheimer's San Francisco office and report to Robin Graham, the firm's Head of Technology Investment Banking.